The present invention relates to at least one human EPO mimetic hinge core mimetibody or specified portion or variant, including isolated nucleic acids that encode at least one EPO mimetic hinge core mimetibody or specified portion or variant, EPO mimetic hinge core mimetibody or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

 
Web www.patentalert.com

< Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein

< 1,2,4-triazine derivatives, preparation and use thereof in human therapy

> Xanthines with HM74A receptor activity

> Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
~ 00608